Corvus Pharmaceuticals Inc (CRVS)
8.94
+0.70
(+8.50%)
USD |
NASDAQ |
Nov 21, 16:00
8.90
-0.04
(-0.45%)
After-Hours: 20:00
Corvus Pharmaceuticals Price to Book Value: 46.29 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 46.29 |
| November 20, 2024 | 42.67 |
| November 19, 2024 | 43.50 |
| November 18, 2024 | 43.19 |
| November 15, 2024 | 42.41 |
| November 14, 2024 | 44.12 |
| November 13, 2024 | 45.93 |
| November 12, 2024 | 45.00 |
| November 11, 2024 | 48.21 |
| November 08, 2024 | 47.66 |
| November 07, 2024 | 44.38 |
| November 06, 2024 | 44.28 |
| November 05, 2024 | 46.55 |
| November 04, 2024 | 45.49 |
| November 01, 2024 | 45.89 |
| October 31, 2024 | 44.58 |
| October 30, 2024 | 44.38 |
| October 29, 2024 | 44.83 |
| October 28, 2024 | 43.57 |
| October 25, 2024 | 41.91 |
| October 24, 2024 | 38.73 |
| October 23, 2024 | 38.13 |
| October 22, 2024 | 39.08 |
| October 21, 2024 | 38.13 |
| October 18, 2024 | 36.36 |
| Date | Value |
|---|---|
| October 17, 2024 | 36.36 |
| October 16, 2024 | 37.07 |
| October 15, 2024 | 33.89 |
| October 14, 2024 | 34.24 |
| October 11, 2024 | 31.92 |
| October 10, 2024 | 29.30 |
| October 09, 2024 | 30.21 |
| October 08, 2024 | 29.96 |
| October 07, 2024 | 28.04 |
| October 04, 2024 | 28.44 |
| October 03, 2024 | 26.53 |
| October 02, 2024 | 26.63 |
| October 01, 2024 | 25.67 |
| September 30, 2024 | 26.63 |
| September 27, 2024 | 6.289 |
| September 26, 2024 | 6.215 |
| September 25, 2024 | 6.350 |
| September 24, 2024 | 6.325 |
| September 23, 2024 | 6.643 |
| September 20, 2024 | 7.217 |
| September 19, 2024 | 6.850 |
| September 18, 2024 | 6.692 |
| September 17, 2024 | 6.716 |
| September 16, 2024 | 7.058 |
| September 13, 2024 | 6.228 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4096
Minimum
Sep 27 2022
48.21
Maximum
Nov 11 2024
2.873
Average
1.540
Median
Price to Book Value Benchmarks
| Azenta Inc | 1.173 |
| Perspective Therapeutics Inc | 0.6173 |
| Atara Biotherapeutics Inc | -- |
| Clearside Biomedical Inc | -- |
| Quanterix Corp | 1.336 |
Price to Book Value Related Metrics
| Price | 8.94 |
| Earnings Yield | -10.29% |
| Market Cap | 574.46M |